Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley T Hyman

Showing results (1-10 of 578) with videos related to

Pageof 58
Sort By:
Nature Neuroscience|December 29, 2010
Caspase activation without apoptosis: insight into Aβ initiation of neurodegenerationBradley T Hyman
Alzheimer Disease and Associated Disorders|November 30, 2006
The natural history of Alzheimer disease dissected through multiphoton imaging of transgenic miceBradley T Hyman
Archives of Neurology|April 13, 2011
Amyloid-dependent and amyloid-independent stages of Alzheimer diseaseBradley T Hyman
Neuron|June 20, 2014
Tau propagation, different tau phenotypes, and prion-like properties of tauBradley T Hyman
The Lancet. Neurology|September 20, 2024
Amyloid removal and the appearance of brain volume lossBradley T Hyman
Annals of Medicine|October 10, 2002
Disordered proteins in dementiaMartin Ingelsson, Bradley T Hyman
Nature Reviews. Neuroscience|May 19, 2012
Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiologyBradley T Hyman, Junying Yuan
Frontiers in Neuroscience|April 8, 2021
Quantitative Methods for the Detection of Tau Seeding Activity in Human BiofluidsAurelien Lathuiliere, Bradley T Hyman
Annals of Neurology|July 22, 2014
Failure analysis of clinical trials to test the amyloid hypothesisBradley T Hyman, Peter Sorger
Journal of Neuroimmunology|January 5, 2002
GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease?MengQi Xia, Bradley T Hyman
Pageof 58

Showing results (1-10 of 578) with videos related to

Sort By:
Pageof 58
Nature Neuroscience|December 29, 2010
Caspase activation without apoptosis: insight into Aβ initiation of neurodegenerationBradley T Hyman
Alzheimer Disease and Associated Disorders|November 30, 2006
The natural history of Alzheimer disease dissected through multiphoton imaging of transgenic miceBradley T Hyman
Archives of Neurology|April 13, 2011
Amyloid-dependent and amyloid-independent stages of Alzheimer diseaseBradley T Hyman
Neuron|June 20, 2014
Tau propagation, different tau phenotypes, and prion-like properties of tauBradley T Hyman
The Lancet. Neurology|September 20, 2024
Amyloid removal and the appearance of brain volume lossBradley T Hyman
Annals of Medicine|October 10, 2002
Disordered proteins in dementiaMartin Ingelsson, Bradley T Hyman
Nature Reviews. Neuroscience|May 19, 2012
Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiologyBradley T Hyman, Junying Yuan
Frontiers in Neuroscience|April 8, 2021
Quantitative Methods for the Detection of Tau Seeding Activity in Human BiofluidsAurelien Lathuiliere, Bradley T Hyman
Annals of Neurology|July 22, 2014
Failure analysis of clinical trials to test the amyloid hypothesisBradley T Hyman, Peter Sorger
Journal of Neuroimmunology|January 5, 2002
GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease?MengQi Xia, Bradley T Hyman
Pageof 58